Nektar Therapeutics (NKTR) Times Interest Earned (2010 - 2020)

Nektar Therapeutics' Times Interest Earned history runs 11 years deep, the most recent figure standing at -$120.11 for Q2 2020.

• In Q2 2020, Times Interest Earned fell 466.17% year-over-year to -$120.11; the TTM figure through Mar 2021 stood at -$619.59 (down 2948.56% YoY), while the FY2020 annual figure was -$62.05, down 200.5% from the prior year.
• Times Interest Earned was -$120.11 for Q2 2020 at Nektar Therapeutics, down from -$21.54 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $180.8 in Q2 2018 to a low of -$120.11 in Q2 2020.
• Historically, Times Interest Earned has averaged -$7.09 across 5 years, with a median of -$13.16 in 2017.
• The sharpest annual moves came in 2016 and 2018: Times Interest Earned sank 5977.31% in 2016, then soared 2066.6% in 2018.
• A 5-year view of Times Interest Earned shows it stood at -$5.79 in 2016, then increased by 26.33% to -$4.27 in 2017, then sank by 334.1% to -$18.52 in 2018, then retreated by 9.05% to -$20.2 in 2019, then tumbled by 494.63% to -$120.11 in 2020.
• The last three Times Interest Earned figures came in at -$120.11 (Q2 2020), -$21.54 (Q1 2020), and -$20.2 (Q4 2019), per Business Quant data.